Clinical trial · Observational
NEMO - an App for Side Effect Management in Oncology
NCT04493450CI-TRIAL-00046388NEMOunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study investigates the use of digital and standardized documentation by patients of frequently occurring adverse events in oncological therapies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Patients | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Documentation of cancer treatment side effects | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Smartphone-users
- description
- Cancer patients who use smartphones
- interventionNames
- Other: Documentation of cancer treatment side effects
Primary outcomes (2)
- measure
- Phase I: Patient acceptance of a new medium of communication
- timeFrame
- 6 months
- description
- Acceptance of documentation of occurring side effects of oncological therapies with new communication media
- measure
- Phase II: Change of occurred adverse events
- timeFrame
- 6 months
- description
- Changes of side effects by at least 1 degree according to CTCAE scoring in comparison to the study start
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * infusional combination therapy with at least two chemotherapy substances with or without further targeted therapies * combination of at least two immune-checkpoint inhibitors * able to read and understand German Exclusion Criteria: Participants who meet any of the following criteria will be excluded: * severe neurological disorders * severe psychiatric disorders
References
Publications (1)
- DERIVEDKestler AMR, Kuhlwein SD, Kraus JM, Schwab JD, Szekely R, Thiam P, Huhne R, Jahn N, Furstberger A, Ikonomi N, Balig J, Schuler R, Kuhn P, Steger F, Seufferlein T, Kestler HA. Digitalization of adverse event management in oncology to improve treatment outcome-A prospective study protocol. PLoS One. 2021 Jun 4;16(6):e0252493. doi: 10.1371/journal.pone.0252493. eCollection 2021. PMID 34086740